Rocket Lab: Bullish Article Pits Optimism Against DeepValue's WAIT Rating

What happened

A Seeking Alpha article published ahead of Rocket Lab's Q1 2026 earnings reiterates a Buy rating with over 25% upside, citing strong Space Systems margin expansion, a 73% YoY backlog increase to $1.85B, and recent acquisitions like Mynaric and Geost. However, the DeepValue Master Report holds a WAIT rating with a conviction of 4.0, highlighting the January 2026 Neutron tank rupture, reliance on equity financing ($1.12B ATM in FY2025 plus $474M in April 2026), and risks from fixed-price program execution. The report sets an attractive entry at $60 and trim above $95, with a base case value of $78. The article's bullish tone contrasts with the report's caution, emphasizing that near-term proof of HASTE cadence and Neutron timeline adherence is required to justify the current valuation.

Implication

Long-term investors should wait for evidence of execution on HASTE (multiple flights per quarter) and Space Systems backlog conversion before adding. The stock's risk/reward is skewed to downside if Neutron slips past Q4 2026 or fixed-price catch-up adjustments worsen. A disciplined entry near $60 offers a better margin of safety.

Thesis delta

The bullish Seeking Alpha article reflects the market's optimistic narrative that the DeepValue report warns is overcrowded and unsupported by operating proofs. The key shift is that while the article sees growth catalysts as imminent, the report's WAIT rating implies these catalysts are not yet derisked, making the current price vulnerable to disappointment. The counter-narrative emphasizes that backlog growth and margin expansion must be validated by cash flow and Neutron milestones, not just contract wins.